Advancing powder compaction analysis with the new Gamlen D series
Gamlen Tableting D series dynamic powder compaction analyser.
D-series analysers are supplied with new 'in-die' and 'out-of-die' compaction analysis software that generates tablet detachment and ejection data with full profiles.
Designed for advanced tableting research, Gamlen Tableting’s new flagship D series dynamic powder compaction analysers feature dwell time control from 90 milliseconds to 60 seconds. D-series analysers are supplied with new 'in-die' and 'out-of-die' compaction analysis software that generates tablet detachment and ejection data with full profiles including strain data, Heckel and Kawakita plots. An optional add-on, the Tablet Tensile Analyzer (TTA), automatically calculates tablet density and solid fraction, and tablet tensile fracture stress.
Michael Gamlen, Managing Director, commented: “The D-series will change the way scientists characterise materials. The key element of the D series is our unique dynamic compaction analysis software, which allows researchers to characterise the elasticity and plasticity of materials at each compaction event, as well as their lubricity and punch detachment behaviour. This is in addition to recording, in real-time, compaction and ejection profiles of an API, excipient, or drug formulation. Researchers will now be able to create a database of material-specific data to support a wide variety of investigations, such as screening for compatible excipients, and enabling accelerated formulation and process development and scale-up to manufacturing.”
Tablet tensile strength can be measured on a D-series instrument via an included high-sensitivity load cell, or alternatively by using the Gamlen Tablet Tensile Analyzer. The Gamlen Tablet Tensile Analyzer is a complementary stand-alone system which measures tablet fracture stress properties in addition to out-of-die weight and thickness of a tablet produced on a D-series instrument. The included TTA software package automatically captures all of these parameters and produces Compaction Triangle plots of compactibility, compressibility, and tabletability.
With a rapidly expanding product range, Gamlen Tableting has transformed the entire Gamlen product line to include the Gamlen M series, for small-scale manufacture of tablets under tightly controlled conditions, and the R series (formerly known as the GTP-1) to support fundamental tableting research and development in a university or company environment.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.